nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—Ifenprodil—GRIN2B—Parkinson's disease	0.011	0.23	CrCbGaD
Ritodrine—Diethylstilbestrol—COMT—Parkinson's disease	0.0102	0.214	CrCbGaD
Ritodrine—Dobutamine—COMT—Parkinson's disease	0.00969	0.203	CrCbGaD
Ritodrine—GALR3—head—Parkinson's disease	0.00773	0.213	CbGeAlD
Ritodrine—GALR3—cerebellum—Parkinson's disease	0.0069	0.19	CbGeAlD
Ritodrine—Diethylstilbestrol—CYP2E1—Parkinson's disease	0.00476	0.0998	CrCbGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00473	0.00516	CbGpPWpGaD
Ritodrine—ADRB2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.0047	0.00513	CbGpPWpGaD
Ritodrine—ADRB2—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.0047	0.00513	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—DGKQ—Parkinson's disease	0.00464	0.00507	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GPR37—Parkinson's disease	0.00464	0.00507	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00464	0.00506	CbGpPWpGaD
Ritodrine—PGD—NRF2 pathway—GSTM1—Parkinson's disease	0.00453	0.00495	CbGpPWpGaD
Ritodrine—PGD—NRF2 pathway—HGF—Parkinson's disease	0.00453	0.00495	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00449	0.0049	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.00448	0.00489	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00424	0.00463	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 signaling events—HGF—Parkinson's disease	0.00422	0.00461	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00421	0.0046	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00406	0.00443	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00406	0.00443	CbGpPWpGaD
Ritodrine—ADRB2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00392	0.00428	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GRK5—Parkinson's disease	0.00387	0.00423	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00371	0.00405	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—HTR1A—Parkinson's disease	0.00366	0.00399	CbGpPWpGaD
Ritodrine—PGD—Disease—VPS35—Parkinson's disease	0.00362	0.00395	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—TAC1—Parkinson's disease	0.0036	0.00393	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—DRD1—Parkinson's disease	0.00353	0.00385	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GRK5—Parkinson's disease	0.00352	0.00384	CbGpPWpGaD
Ritodrine—Formoterol—CYP2D6—Parkinson's disease	0.00349	0.0733	CrCbGaD
Ritodrine—Arformoterol—CYP2D6—Parkinson's disease	0.00349	0.0733	CrCbGaD
Ritodrine—GALR3—GPCR downstream signaling—GRM4—Parkinson's disease	0.00347	0.00379	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—DRD3—Parkinson's disease	0.00342	0.00373	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Other—ADORA2A—Parkinson's disease	0.00338	0.00369	CbGpPWpGaD
Ritodrine—PGD—forebrain—Parkinson's disease	0.00338	0.0928	CbGeAlD
Ritodrine—PGD—Disease—MCCC1—Parkinson's disease	0.00337	0.00368	CbGpPWpGaD
Ritodrine—GALR3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00332	0.00362	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VPS35—Parkinson's disease	0.00331	0.00361	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PENK—Parkinson's disease	0.00329	0.0036	CbGpPWpGaD
Ritodrine—ADRB2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00329	0.00359	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00325	0.00355	CbGpPWpGaD
Ritodrine—PGD—Disease—TALDO1—Parkinson's disease	0.00317	0.00346	CbGpPWpGaD
Ritodrine—PGD—Disease—OMD—Parkinson's disease	0.00317	0.00346	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00316	0.00345	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GRM4—Parkinson's disease	0.00315	0.00344	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—HTR7—Parkinson's disease	0.00309	0.00338	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—DRD2—Parkinson's disease	0.00309	0.00338	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PDYN—Parkinson's disease	0.00301	0.00329	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PENK—Parkinson's disease	0.00299	0.00327	CbGpPWpGaD
Ritodrine—PGD—cardiovascular system—Parkinson's disease	0.00285	0.0785	CbGeAlD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00284	0.00311	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ND3—Parkinson's disease	0.00282	0.00308	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MCCC1—Parkinson's disease	0.00282	0.00308	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GRM5—Parkinson's disease	0.0028	0.00306	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Other—DRD3—Parkinson's disease	0.00275	0.003	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—DGKQ—Parkinson's disease	0.00274	0.00299	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GPR37—Parkinson's disease	0.00274	0.00299	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PDYN—Parkinson's disease	0.00274	0.00299	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0027	0.00295	CbGpPWpGaD
Ritodrine—PGD—Metabolism—OMD—Parkinson's disease	0.00265	0.00289	CbGpPWpGaD
Ritodrine—PGD—Metabolism—TALDO1—Parkinson's disease	0.00265	0.00289	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—ADORA2A—Parkinson's disease	0.00264	0.00288	CbGpPWpGaD
Ritodrine—Labetalol—CYP2D6—Parkinson's disease	0.00255	0.0535	CrCbGaD
Ritodrine—PGD—Disease—FBP1—Parkinson's disease	0.00255	0.00279	CbGpPWpGaD
Ritodrine—PGD—Disease—TAF1—Parkinson's disease	0.00255	0.00279	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GRM5—Parkinson's disease	0.00254	0.00278	CbGpPWpGaD
Ritodrine—PGD—Metabolism—NDUFB11—Parkinson's disease	0.00251	0.00274	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00251	0.00274	CbGpPWpGaD
Ritodrine—Diethylstilbestrol—ABCB1—Parkinson's disease	0.00249	0.0523	CrCbGaD
Ritodrine—ADRB2—GPCRs, Other—HTR7—Parkinson's disease	0.00248	0.00271	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—EDN1—Parkinson's disease	0.00248	0.0027	CbGpPWpGaD
Ritodrine—PGD—medulla oblongata—Parkinson's disease	0.00244	0.0671	CbGeAlD
Ritodrine—PGD—Metabolism—GCH1—Parkinson's disease	0.0024	0.00262	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00238	0.0026	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 trafficking events—INS—Parkinson's disease	0.00234	0.00256	CbGpPWpGaD
Ritodrine—PGD—midbrain—Parkinson's disease	0.00223	0.0613	CbGeAlD
Ritodrine—ADRB2—G alpha (s) signalling events—DRD1—Parkinson's disease	0.00221	0.00242	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RIT2—Parkinson's disease	0.00219	0.00239	CbGpPWpGaD
Ritodrine—PGD—spinal cord—Parkinson's disease	0.00217	0.0598	CbGeAlD
Ritodrine—GALR3—GPCR ligand binding—HTR2A—Parkinson's disease	0.00217	0.00236	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00216	0.00236	CbGpPWpGaD
Ritodrine—PGD—Metabolism—DBH—Parkinson's disease	0.00214	0.00233	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GBA—Parkinson's disease	0.00214	0.00233	CbGpPWpGaD
Ritodrine—PGD—Metabolism—FBP1—Parkinson's disease	0.00214	0.00233	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GRK5—Parkinson's disease	0.00208	0.00227	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00207	0.00226	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GPR37—Parkinson's disease	0.00206	0.00225	CbGpPWpGaD
Ritodrine—PGD—Disease—SNCA—Parkinson's disease	0.00204	0.00223	CbGpPWpGaD
Ritodrine—PGD—Disease—RPL6—Parkinson's disease	0.00204	0.00223	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—TAC1—Parkinson's disease	0.00203	0.00222	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—DRD1—Parkinson's disease	0.002	0.00218	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—HTR7—Parkinson's disease	0.00194	0.00212	CbGpPWpGaD
Ritodrine—PGD—head—Parkinson's disease	0.00193	0.0532	CbGeAlD
Ritodrine—GALR3—GPCR downstream signaling—DRD3—Parkinson's disease	0.00193	0.00211	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—HTR1A—Parkinson's disease	0.00188	0.00205	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GRM4—Parkinson's disease	0.00186	0.00203	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—TAC1—Parkinson's disease	0.00185	0.00202	CbGpPWpGaD
Ritodrine—PGD—nervous system—Parkinson's disease	0.00183	0.0504	CbGeAlD
Ritodrine—GALR3—Signaling by GPCR—DRD1—Parkinson's disease	0.00181	0.00198	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0018	0.00197	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PENK—Parkinson's disease	0.00177	0.00193	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAG—Parkinson's disease	0.00177	0.00193	CbGpPWpGaD
Ritodrine—PGD—central nervous system—Parkinson's disease	0.00176	0.0485	CbGeAlD
Ritodrine—GALR3—Signaling by GPCR—DRD3—Parkinson's disease	0.00175	0.00192	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—DRD2—Parkinson's disease	0.00175	0.00191	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—HTR7—Parkinson's disease	0.00175	0.00191	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00174	0.0019	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Other—HTR2A—Parkinson's disease	0.00174	0.0019	CbGpPWpGaD
Ritodrine—PGD—cerebellum—Parkinson's disease	0.00172	0.0474	CbGeAlD
Ritodrine—GALR3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00164	0.00179	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PDYN—Parkinson's disease	0.00162	0.00176	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00159	0.00174	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—DRD2—Parkinson's disease	0.00159	0.00173	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—HTR7—Parkinson's disease	0.00159	0.00173	CbGpPWpGaD
Ritodrine—PGD—Metabolism—DDC—Parkinson's disease	0.00157	0.00171	CbGpPWpGaD
Ritodrine—PGD—Disease—RPL14—Parkinson's disease	0.00155	0.00169	CbGpPWpGaD
Ritodrine—PGD—Disease—RPL23A—Parkinson's disease	0.00155	0.00169	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GFAP—Parkinson's disease	0.00152	0.00166	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GRM5—Parkinson's disease	0.0015	0.00164	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GSTA4—Parkinson's disease	0.00148	0.00162	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00147	0.00161	CbGpPWpGaD
Ritodrine—PGD—Disease—RPS8—Parkinson's disease	0.00144	0.00157	CbGpPWpGaD
Ritodrine—PGD—Disease—FGF20—Parkinson's disease	0.00144	0.00157	CbGpPWpGaD
Ritodrine—PGD—brain—Parkinson's disease	0.0014	0.0385	CbGeAlD
Ritodrine—ADRB2—GPCR ligand binding—GRM4—Parkinson's disease	0.0014	0.00153	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—EDN1—Parkinson's disease	0.0014	0.00153	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PLA2G6—Parkinson's disease	0.00133	0.00146	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PENK—Parkinson's disease	0.00133	0.00145	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MAOB—Parkinson's disease	0.00132	0.00144	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGF20—Parkinson's disease	0.00132	0.00144	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADORA2A—Parkinson's disease	0.00128	0.00139	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00128	0.00139	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—EDN1—Parkinson's disease	0.00127	0.00139	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00126	0.00138	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00123	0.00135	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00122	0.00134	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PDYN—Parkinson's disease	0.00121	0.00132	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00119	0.0013	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—INSR—Parkinson's disease	0.00118	0.00129	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00116	0.00127	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GRM5—Parkinson's disease	0.00113	0.00123	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGB—Parkinson's disease	0.00111	0.00122	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—HTR2A—Parkinson's disease	0.00111	0.00121	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HTR1A—Parkinson's disease	0.00111	0.00121	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00109	0.00119	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TAC1—Parkinson's disease	0.00109	0.00119	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00108	0.00118	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00108	0.00118	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00108	0.00118	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—DRD1—Parkinson's disease	0.00107	0.00117	CbGpPWpGaD
Ritodrine—PGD—Disease—ADRBK1—Parkinson's disease	0.00106	0.00116	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00106	0.00115	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.00106	0.00115	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00106	0.00115	CbGpPWpGaD
Ritodrine—PGD—Disease—HSPA1A—Parkinson's disease	0.00105	0.00115	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—DRD3—Parkinson's disease	0.00104	0.00113	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00102	0.00112	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP2D6—Parkinson's disease	0.000981	0.00107	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000968	0.00106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000966	0.00106	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CTGF—Parkinson's disease	0.000963	0.00105	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000959	0.00105	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HTR7—Parkinson's disease	0.000938	0.00102	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—DRD2—Parkinson's disease	0.000938	0.00102	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000924	0.00101	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000924	0.00101	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP2E1—Parkinson's disease	0.000897	0.00098	CbGpPWpGaD
Ritodrine—PGD—Metabolism—NQO1—Parkinson's disease	0.000887	0.000969	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000882	0.000963	CbGpPWpGaD
Ritodrine—PGD—Metabolism—TH—Parkinson's disease	0.000875	0.000955	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYCS—Parkinson's disease	0.00084	0.000917	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000832	0.000909	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.00082	0.000895	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.000804	0.000878	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.000801	0.000874	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000791	0.000863	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF2—Parkinson's disease	0.000786	0.000858	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.000778	0.00085	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF1R—Parkinson's disease	0.00076	0.000829	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000756	0.000825	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000753	0.000822	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EDN1—Parkinson's disease	0.000751	0.000819	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.00075	0.000819	CbGpPWpGaD
Ritodrine—PGD—Metabolism—COMT—Parkinson's disease	0.000744	0.000812	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00074	0.000808	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GSTP1—Parkinson's disease	0.00074	0.000808	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MAOA—Parkinson's disease	0.000738	0.000806	CbGpPWpGaD
Ritodrine—PGD—Metabolism—HMOX1—Parkinson's disease	0.00073	0.000797	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000718	0.000784	CbGpPWpGaD
Ritodrine—PGD—Disease—MTHFR—Parkinson's disease	0.000718	0.000784	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000704	0.000769	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000704	0.000769	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ABCB1—Parkinson's disease	0.000701	0.000765	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NGF—Parkinson's disease	0.00069	0.000753	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000686	0.000749	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.000681	0.000743	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GSTM1—Parkinson's disease	0.00068	0.000742	CbGpPWpGaD
Ritodrine—PGD—Disease—APOE—Parkinson's disease	0.000668	0.000729	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HTR2A—Parkinson's disease	0.000657	0.000717	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GPX1—Parkinson's disease	0.000651	0.000711	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000648	0.000707	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000637	0.000696	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000624	0.000681	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000624	0.000681	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.000623	0.00068	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—APOE—Parkinson's disease	0.00061	0.000666	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MTHFR—Parkinson's disease	0.000601	0.000656	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000579	0.000632	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000571	0.000623	CbGpPWpGaD
Ritodrine—PGD—Disease—INS—Parkinson's disease	0.000571	0.000623	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000564	0.000615	CbGpPWpGaD
Ritodrine—PGD—Metabolism—APOE—Parkinson's disease	0.00056	0.000611	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000542	0.000592	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—INS—Parkinson's disease	0.000522	0.000569	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.000499	0.000545	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000493	0.000538	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000492	0.000537	CbGpPWpGaD
Ritodrine—PGD—Metabolism—INS—Parkinson's disease	0.000478	0.000522	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	0.000473	0.000516	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00047	0.000513	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000463	0.000506	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000454	0.000496	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00044	0.00048	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000427	0.000466	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	0.000424	0.000463	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	0.000421	0.000459	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	0.000412	0.00045	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000411	0.000448	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAG—Parkinson's disease	0.000402	0.000439	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PENK—Parkinson's disease	0.000402	0.000439	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	0.000399	0.000436	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000398	0.000434	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000398	0.000434	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CASP3—Parkinson's disease	0.000388	0.000424	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL6—Parkinson's disease	0.000386	0.000421	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000373	0.000407	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	0.000368	0.000402	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	0.000361	0.000394	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	0.000361	0.000394	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAPK8—Parkinson's disease	0.000357	0.00039	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	0.000346	0.000378	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	0.000342	0.000373	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000319	0.000348	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	0.0003	0.000327	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000291	0.000317	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	0.000289	0.000316	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000279	0.000304	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—INSR—Parkinson's disease	0.000268	0.000293	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGB—Parkinson's disease	0.000254	0.000277	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000253	0.000276	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	0.000252	0.000275	CbGpPWpGaD
Ritodrine—PGD—Disease—IL6—Parkinson's disease	0.000249	0.000272	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	0.000248	0.000271	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	0.000244	0.000266	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	0.000236	0.000258	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6—Parkinson's disease	0.000228	0.000249	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	0.00022	0.000241	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	0.000213	0.000233	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	0.000213	0.000233	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	0.000179	0.000195	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	0.000173	0.000189	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	0.000171	0.000187	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NGF—Parkinson's disease	0.000157	0.000171	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	0.000149	0.000163	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—APOE—Parkinson's disease	0.000139	0.000152	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—INS—Parkinson's disease	0.000119	0.00013	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	8.84e-05	9.65e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	8.78e-05	9.59e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	8.12e-05	8.87e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6—Parkinson's disease	5.19e-05	5.66e-05	CbGpPWpGaD
